Skip to main content Accessibility help
  • Print publication year: 2013
  • Online publication date: May 2013

Chapter 15 - The acute management of patients with psychiatric complications of chronic illness or chronic pain


1. GallegoL, BarreiroP, López-IborJJ. Diagnosis and clinical features of major neuropsychiatric disorders in HIV infection. AIDS Rev. 2011;13(3):171–179.
2. TreismanG, AngelinoA. Interrelation between psychiatric disorders and the prevention and treatment of HIV infection. Clin Infect Dis. 2007;45(Suppl 4):S313–S317.
3. LarsonSL, ClarkMR, EatonWW. Depressive disorder as a long-term antecedent risk factor for incident back pain: a 13-year follow-up study from the Baltimore Epidemiological Catchment Area sample. Psychol Med. 2004;34(2):211–219.
4. SchieirO, ThombsBD, HudsonM, et al. Symptoms of depression predict the trajectory of pain among patients with early inflammatory arthritis: a path analysis approach to assessing change. J Rheumatol. 2009;36(2):231–239.
5. DershJ, PolatinPB, GatchelRJ. Chronic pain and psychopathology: research findings and theoretical considerations. Psychosom Med. 2002;64(5):773–786.
6. RahmanA, ReedE, UnderwoodM, ShipleyME, OmarRZ. Factors affecting self-efficacy and pain intensity in patients with chronic musculoskeletal pain seen in a specialist rheumatology pain clinic. Rheumatology (Oxford). 2008;47(12):1803–1808.
7. IlgenMA, ZivinK, McCammonRJ, ValensteinM. Pain and suicidal thoughts, plans and attempts in the United States. Gen Hosp Psychiatry. 2008;30(6):521–527.
8. BairMJ, WuJ, DamushTM, SutherlandJM, KroenkeK. Association of depression and anxiety alone and in combination with chronic musculoskeletal pain in primary care patients. Psychosom Med. 2008;70(8):890–897.
9. LinEH, KatonW, Von KorffM, et al; IMPACT Investigators. Effect of improving depression care on pain and functional outcomes among older adults with arthritis: a randomized controlled trial. JAMA. 2003;290(18):2428–2429.
10. Rosenzweig-LipsonS, DunlopJ, MarquisKL. 5-HT2C receptor agonists as an innovative approach for psychiatric disorders. Drug News Perspect. 2007;20(9):565–571.
11. McWilliamsLA, CoxBJ, EnnsMW. Mood and anxiety disorders associated with chronic pain: an examination in a nationally representative sample. Pain. 2003;106(1–2):127–133.
12. BreslauN, DavisGC. Migraine, physical health and psychiatric disorder: a prospective epidemiologic study in young adults. J Psychiatr Res. 1993;27(2):211–221.
13. DammenT, EkebergØ, ArnesenH, FriisS. Health-related quality of life in non-cardiac chest pain patients with and without panic disorder. Int J Psychiatry Med. 2008;38(3):271–286.
14. LiebschutzJ, SaitzR, BrowerV, et al. PTSD in urban primary care: high prevalence and low physician recognition. J Gen Intern Med. 2007;22(6):719–726.
15. JeneweinJ, WittmannL, MoergeliH, CreutzigJ, SchnyderU. Mutual influence of posttraumatic stress disorder symptoms and chronic pain among injured accident survivors: a longitudinal study. J Trauma Stress. 2009;22(6):540–548.
16. SydenhamT. The works of Thomas Sydenham MD, translated from the Latin edition of Dr. Greenhill. London: The Sydenham Society, 1850.
17. HansenNB, CavanaughCE, VaughanEL, et al. The influence of personality disorder indication, social support, and grief on alcohol and cocaine use among HIV-positive adults coping with AIDS-related bereavement. AIDS Behav. 2009;13:375–384.
18. BennettWR, JoeschJM, MazurM, et al. Characteristics of HIV-positive patients treated in a psychiatric emergency department. Psychiatr Serv. 2009;60:398–401.
19. WeissmanMM. The epidemiology of personality disorders: a 1990 update. J Personal Disord. 1993;7(suppl):44–62.
20. LaddGT, PetryNM. Antisocial personality in treatment-seeking cocaine abusers: psychosocial functioning and HIV risk. J Subst Abuse Treat. 2003;24:323–330.
21. VendrigAA. The Minnesota Multiphasic Personality Inventory and chronic pain: a conceptual analysis of a long-standing but complicated relationship. Clin Psychol Rev. 2000;20:533–559.
22. VendrigAA, DerksenJJ, de MeyHR. MMPI-2 Personality Psychopathology Five (PSY-5) and prediction of treatment outcome for patients with chronic back pain. J Pers Assess. 2000;74:423–438.
23. CiceroTJ, InciardiJA, SurrattH. Trends in the use and abuse of branded and generic extended release oxycodone and fentanyl products in the United States. Drug Alcohol Depend. 2007;91:115–120.
24. McCrackenLM, HoskinsJ, EcclestonC. Concerns about medication and medication use in chronic pain. J Pain. 2006;7:726–734.
25. PelesE, SchreiberS, GordonJ, AdelsonM. Significantly higher methadone dose for methadone maintenance treatment (MMT) patients with chronic pain. Pain. 2005;113:340–346.
26. RosenblumA, JosephH, FongC, KipnisS, ClelandC, PortenoyRK. Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA. 2003;289:2370–2378.
27. PassikSD, KirshKL, DonaghyKB, PortenoyRK. Pain and aberrant drug-related behaviors in medically ill patients with and without histories of substance abuse. Clin J Pain. 2006;22:173–181.
28. ClarkMR, StollerKB, BroonerRK. Assessment and management of chronic pain in individuals seeking treatment for opioid dependence disorder. Can J Psychiatry. 2008;53:496–508.
29. DeviS. USA hones in on prescription drug abuse. Lancet 2011;378(9790):473–474.
30. OssipovMH, LaiJ, KingT, VanderahTW, PorrecaF. Underlying mechanisms of pronociceptive consequences of prolonged morphine exposure. Biopolymers. 2005;80(2–3):319–324.
31. ClarkMR. Psychiatric issues in chronic pain. Curr Psychiatry Rep. 2009;11(3):243–245.
32. StockhorstU, SteingrueberHJ, EnckP, KlosterhalfenS. Pavlovian conditioning of nausea and vomiting. Auton Neurosci. 2006;129(1–2):50–57.
33. ExtonMS, von AuerAK, Buske-KirschbaumA, StockhorstU, GöbelU, SchedlowskiM. Pavlovian conditioning of immune function: animal investigation and the challenge of human application. Behav Brain Res. 2000;110(1–2):129–141.
34. BouhuysA, JustesenDR. Allergic and classically conditioned asthma in guinea pigs. Science. 1971;173(991):82.
35. GreeleyJ. Pavlovian conditioning of pain regulation: insights from pharmacological conditioning with morphine and naloxone. Biol Psychol. 1989;28(1):41–46.
36. PilowskyI. Abnormal illness behaviour. Br J Med Psychol. 1969;42(4):347–351.
37. FordyceWE, FowlerRS, DeLateurB. An application of behavior modification technique to a problem of chronic pain. Behav Res Ther. 1968;6(1):105–107.
38. TurkDC, SwansonKS, TunksER. Psychological approaches in the treatment of chronic pain patients – when pills, scalpels, and needles are not enough. Can J Psychiatry. 2008;53(4):213–223.
39. TurkDC, OkifujiA. What factors affect physicians’ decisions to prescribe opioids for chronic noncancer pain patients?Clin J Pain. 1997;13(4):330–336.
40. FeeC. Death of a difficult patient. Ann Emerg Med. 2001;37(3):3.
41. SonnenbergA. Personal view: passing the buck and taking a free ride – a game-theoretical approach to evasive management strategies in gastroenterology. Aliment Pharmacol Ther. 2005;22(6):513.
42. ReevesRR, DouglasSP, GarnerRT, ReynoldsMD, SilversA. The individual rights of the difficult patient. Hastings Cent Rep. 2007;37(2):13; discussion 13–15.
43. KrebsEE, GarrettJM, KonradTR. The difficult doctor? Characteristics of physicians who report frustration with patients: an analysis of survey data. BMC Health Serv Res. 2006;6:128.
44. BatchelorJ, FreemanMS. Spectrum: the clinician and the “difficult” patient. S D J Med. 2001;54(11):453–456.
45. HaasLJ, LeiserJP, MagillMK, SanyerON. Management of the difficult patient. Am Fam Physician. 2005;72(10):2063–2068.